DHTKD1 and neoplasm: One explanation for these results was that, in contrast to MCA-205-E1A-OVA cells, MCA-205-OVA or MCA-205-E1A-Δp300-OVA failed to induce a productive OVA–specific anti-tumor immune response in vivo.